![George Sekulich](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
George Sekulich
President chez EMMAUS LIFE SCIENCES, INC.
Fortune : 39 $ au 30/06/2024
Profil
Mr. George Sekulich is a Co-President, Director & Chief Commercial Officer at Emmaus Life Sciences, Inc. and a Chief Information Officer at EMI Holding, Inc. He is on the Board of Directors at Emmaus Life Sciences, Inc. Mr. Sekulich was previously employed as an Owner by Magellan Network Systems, Inc. He received his undergraduate degree from California State University-Dominguez Hills.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
15/03/2024 | 385 ( 0,00% ) | 39 $ | 30/06/2024 |
Postes actifs de George Sekulich
Sociétés | Poste | Début |
---|---|---|
EMMAUS LIFE SCIENCES, INC. | President | 23/08/2023 |
EMI Holding, Inc.
![]() EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology EMI Holding, Inc. discovers, develops, and commercializes treatments and therapies for rare diseases. The firm also engages in the marketing and sale of NutreStore L-glutamine powder for oral solution, a treatment for short bowel syndrome and the sale of L-glutamine as a nutritional supplement under the brand name AminoPure. The company was founded by Yutaka Niihara in 1987 and is headquartered in Torrance, CA. | Directeur Technique/Scientifique/R&D | 01/09/2014 |
Anciens postes connus de George Sekulich
Sociétés | Poste | Fin |
---|---|---|
Magellan Network Systems, Inc. | Corporate Officer/Principal | - |
Formation de George Sekulich
California State University-Dominguez Hills | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
EMMAUS LIFE SCIENCES, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
EMI Holding, Inc.
![]() EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology EMI Holding, Inc. discovers, develops, and commercializes treatments and therapies for rare diseases. The firm also engages in the marketing and sale of NutreStore L-glutamine powder for oral solution, a treatment for short bowel syndrome and the sale of L-glutamine as a nutritional supplement under the brand name AminoPure. The company was founded by Yutaka Niihara in 1987 and is headquartered in Torrance, CA. | Health Technology |
Magellan Network Systems, Inc. |